SE9101642D0
(sv)
*
|
1991-05-30 |
1991-05-30 |
Kabi Pharmacia Ab |
Phospholipids
|
DK198991D0
(da)
*
|
1991-12-10 |
1991-12-10 |
Simanol A S |
Fiskeprodukt
|
SE9200541D0
(sv)
*
|
1992-02-24 |
1992-02-24 |
Kabi Pharmacia Ab |
New usee of omega-3-fatty acids
|
DE69401506T2
(de)
*
|
1993-04-29 |
1997-09-11 |
Norsk Hydro As |
Verfahren zur chromatografischer fraktionierung von fettsäuren und ihre derivaten
|
US20050027004A1
(en)
*
|
1993-06-09 |
2005-02-03 |
Martek Biosciences Corporation |
Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
|
WO1995009622A1
(en)
*
|
1993-10-06 |
1995-04-13 |
Peptide Technology Limited |
Polyunsaturated fatty acids and uses thereof
|
IT1264987B1
(it)
*
|
1993-12-14 |
1996-10-17 |
Prospa Bv |
Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
|
GB9404483D0
(en)
*
|
1994-03-08 |
1994-04-20 |
Norsk Hydro As |
Refining marine oil compositions
|
IT1274734B
(it)
*
|
1994-08-25 |
1997-07-24 |
Prospa Bv |
Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
|
EP1886679A3
(de)
*
|
1995-06-07 |
2008-05-28 |
Martek Biosciences Corporation |
Verfahren zur Regulierung des Gehalts an mehrfach ungesättigten Fettsäuren in verschiedenen Geweben
|
KR100293297B1
(ko)
*
|
1995-11-24 |
2001-08-07 |
씨.지. 온닝크 |
어유기재조성물
|
US5866150A
(en)
*
|
1996-03-20 |
1999-02-02 |
Aquaculture Technology Incorporated |
Antibacterially active extracts from the marine algae chaetoceros and methods of use
|
US6313167B1
(en)
|
1997-06-16 |
2001-11-06 |
Nippon Suisan Kaisha Ltd. |
Composition having capability of removing risk factor during exercise
|
US20020037876A1
(en)
*
|
1998-06-25 |
2002-03-28 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
IL121165A0
(en)
*
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
CA2306908C
(en)
*
|
1997-10-23 |
2004-06-08 |
The Procter & Gamble Company |
Fatty acids, soaps, surfactant systems, and consumer products based thereon
|
US6992057B2
(en)
*
|
2000-02-22 |
2006-01-31 |
The Procter & Gamble Company |
Fatty acids, soaps, surfactant systems, and consumer products based thereon
|
NO309795B1
(no)
*
|
1998-07-01 |
2001-04-02 |
Norsk Hydro As |
FremgangsmOte for O stabilisere oljer samt anvendelse derav, fremgangsmOte for O stabilisere pigmenter, og fremgangsmOte for fremstilling av for
|
GB9901809D0
(en)
*
|
1999-01-27 |
1999-03-17 |
Scarista Limited |
Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
|
IT1308613B1
(it)
*
|
1999-02-17 |
2002-01-09 |
Pharmacia & Upjohn Spa |
Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
|
US7112609B2
(en)
*
|
1999-06-01 |
2006-09-26 |
Drugtech Corporation |
Nutritional supplements
|
US6998501B1
(en)
|
1999-08-30 |
2006-02-14 |
Ocean Nutrition Canada Limited |
Nutritional supplement for lowering serum triglyceride and cholesterol levels
|
US6346231B1
(en)
|
1999-10-06 |
2002-02-12 |
Joar Opheim |
Flavored gelatin capsule and method of manufacture
|
US6395778B1
(en)
|
2000-01-11 |
2002-05-28 |
Omegatech, Inc. |
Process for making an enriched mixture of polyunsaturated fatty acid esters
|
ES2298197T3
(es)
*
|
2000-01-31 |
2008-05-16 |
Harting S.A. |
Composiciones que contienen esteres de acidos grasos de fitosterol y de policosanol para reducir el colesterol y los trigliceridos de la sangre.
|
CA2304906A1
(en)
*
|
2000-04-07 |
2001-10-07 |
1411198 Ontario Limited |
13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
|
DK1157692T3
(da)
*
|
2000-05-22 |
2006-02-06 |
Pro Aparts Investimentos E Con |
Sammensætning af fedtsyrer indeholdende mindst 80 vægt-% EPA og DHA, derivater deraf og farmaceutisk anvendelse deraf
|
US6667064B2
(en)
|
2000-08-30 |
2003-12-23 |
Pilot Therapeutics, Inc. |
Composition and method for treatment of hypertriglyceridemia
|
ITMI20010129A1
(it)
*
|
2001-01-25 |
2002-07-25 |
Pharmacia & Upjohn Spa |
Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
|
ITMI20012384A1
(it)
*
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
US8729124B2
(en)
*
|
2002-03-05 |
2014-05-20 |
Pronova Biopharma Norge As |
Use of EPA and DHA in secondary prevention
|
NZ518504A
(en)
*
|
2002-04-22 |
2005-05-27 |
Ind Res Ltd |
Use of near-critical fluids in the separation of saturated and mono-unsaturated fatty acids from urea-containing solutions
|
ATE439127T1
(de)
*
|
2002-06-17 |
2009-08-15 |
Medestea Res & Production S P |
Langkettige ungesättigte sauerstoffhaltige verbindungen und deren verwendung im therapeutischen, kosmetischen und diätetischen bereich
|
SE0202188D0
(sv)
|
2002-07-11 |
2002-07-11 |
Pronova Biocare As |
A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
|
EP2295529B2
(de)
*
|
2002-07-11 |
2022-05-18 |
Basf As |
Verfahren zur Verminderung von Umweltschadstoffen in einem Öl oder einem Fett und Fischfutterprodukt
|
US7279018B2
(en)
|
2002-09-06 |
2007-10-09 |
Fortum Oyj |
Fuel composition for a diesel engine
|
US7041840B2
(en)
*
|
2002-12-18 |
2006-05-09 |
Alberta Research Council Inc. |
Antioxidant triacylglycerols and lipid compositions
|
DE10261061A1
(de)
*
|
2002-12-24 |
2004-07-15 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
|
DE10261067A1
(de)
*
|
2002-12-24 |
2004-08-05 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure
|
US20040235948A1
(en)
*
|
2003-03-05 |
2004-11-25 |
Solvay Pharmaceuticals Gmbh |
Treatment of diabetic patients with omega-3-fatty acids
|
DE10317109A1
(de)
*
|
2003-04-14 |
2004-11-11 |
Cognis Deutschland Gmbh & Co. Kg |
Zubereitungen zur oralen Aufnahme
|
US7759507B2
(en)
|
2003-09-05 |
2010-07-20 |
Abbott Laboratories |
Lipid system and methods of use
|
US8052992B2
(en)
*
|
2003-10-22 |
2011-11-08 |
Enzymotec Ltd. |
Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
|
SE0303513D0
(sv)
|
2003-12-19 |
2003-12-19 |
Pronova Biocare As |
Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
|
ITMI20040069A1
(it)
|
2004-01-21 |
2004-04-21 |
Tiberio Bruzzese |
Uso di composizioni di acidi grassi n-3 ad elevata concentrazione per il trattamento di disturbi del sistema nervoso centrale
|
GB0403247D0
(en)
|
2004-02-13 |
2004-03-17 |
Tillotts Pharma Ag |
A pharmaceutical composition
|
US7022713B2
(en)
*
|
2004-02-19 |
2006-04-04 |
Kowa Co., Ltd. |
Hyperlipemia therapeutic agent
|
EP1600060A1
(de)
|
2004-05-25 |
2005-11-30 |
Cognis IP Management GmbH |
Orale und/oder topische Zusammensetzung enthaltend Prebiotiken und Fettsäuren
|
US20060020031A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Roger Berlin |
Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
|
US20090042979A1
(en)
*
|
2004-08-06 |
2009-02-12 |
Transform Pharmaceuticals Inc. |
Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
|
MX2007001558A
(es)
*
|
2004-08-06 |
2008-03-13 |
Transform Pharmaceuticals Inc |
Formulaciones novedosas de fenofibrato y metodos de tratamiento relacionados.
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
EP1656934A1
(de)
*
|
2004-11-12 |
2006-05-17 |
Cognis IP Management GmbH |
Verwendung von physiologisch aktiven Fettsäuren zur Behandlung von Lipodystrophie
|
EP1656935A1
(de)
*
|
2004-11-12 |
2006-05-17 |
Cognis IP Management GmbH |
Verwendung von physiologisch aktiven Fettsäuren zur Behandlung von Pruritus
|
CN101098690A
(zh)
*
|
2004-12-06 |
2008-01-02 |
瑞莱恩特医药品有限公司 |
用于血脂治疗的ω-3脂肪酸和脂血异常剂
|
CA2589654C
(en)
*
|
2004-12-06 |
2016-02-16 |
Reliant Pharmaceuticals, Inc. |
Omega-3 fatty acids and dyslipidemic agent for lipid therapy
|
US20060135610A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bortz Jonathan D |
Cardiovascular compositions
|
BRPI0607569A2
(pt)
*
|
2005-03-08 |
2009-09-15 |
Reliant Pharmaceuticals Inc |
composição farmacêutica compreendendo estatina e ácidos graxos Èmega-3, na forma de dosagem unitária
|
AU2006242914B2
(en)
*
|
2005-05-04 |
2012-02-02 |
Pronova Biopharma Norge As |
New DHA derivatives and their use as medicaments
|
CN101213281B
(zh)
*
|
2005-05-04 |
2013-03-13 |
普罗诺瓦生物医药挪威公司 |
新的dha衍生物及其作为药物的用途
|
WO2006123550A1
(ja)
*
|
2005-05-16 |
2006-11-23 |
Nippon Suisan Kaisha, Ltd. |
炎症性疾患予防又は治療剤
|
US20060292217A1
(en)
*
|
2005-06-03 |
2006-12-28 |
Schmidt Robbin D |
Nutritional supplement and soft gelatin capsule delivery system
|
AU2006275784A1
(en)
*
|
2005-07-28 |
2007-02-08 |
Reliant Pharmaceuticals, Inc. |
Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
|
ITMI20051560A1
(it)
*
|
2005-08-10 |
2007-02-11 |
Tiberio Bruzzese |
Composizione di acidi grassi n-3 con elevata concentrazione di epa e-o dha e contenente acidi grassi n-6
|
DE102005040463A1
(de)
|
2005-08-26 |
2007-03-01 |
Cognis Ip Management Gmbh |
Verwendung von Gemischen aus Polyphenolen und physiologisch aktiven ungesättigten Fettstoffen
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
US20070104779A1
(en)
*
|
2005-11-07 |
2007-05-10 |
Rongen Roelof M |
Treatment with omega-3 fatty acids and products thereof
|
DE102005054577A1
(de)
|
2005-11-16 |
2007-05-24 |
Cognis Ip Management Gmbh |
Verwendung von Estern ungesättigter, physiologisch aktiver Fettsäuren als Nährmedien für Zellkulturen
|
KR20080073288A
(ko)
*
|
2005-12-09 |
2008-08-08 |
드러그테크 코포레이션 |
정맥내 필수 지방산 에멀젼
|
CA2634139C
(en)
*
|
2005-12-20 |
2015-06-23 |
Cenestra, Llc. |
Omega 3 fatty acid formulations
|
EP1973536A2
(de)
*
|
2006-01-05 |
2008-10-01 |
Reliant Pharmaceuticals, Inc. |
Behandlung von fettleber
|
JP5372525B2
(ja)
|
2006-03-03 |
2013-12-18 |
エフ エム シー コーポレーション |
カプセルの製造方法および該製造方法により製造されるカプセル
|
WO2007103557A2
(en)
|
2006-03-09 |
2007-09-13 |
Reliant Pharmaceuticals, Inc. |
Coating capsules with active pharmaceutical ingredients
|
US8784886B2
(en)
*
|
2006-03-09 |
2014-07-22 |
GlaxoSmithKline, LLC |
Coating capsules with active pharmaceutical ingredients
|
ES2500063T3
(es)
*
|
2006-05-31 |
2014-09-29 |
Mochida Pharmaceutical Co., Ltd. |
Composición para prevenir la aparición de acontecimiento cardiovascular en paciente con riesgo múltiple
|
WO2008011178A2
(en)
*
|
2006-07-21 |
2008-01-24 |
Reliant Pharmaceuticals, Inc. |
Compositions comprising omega-3 fatty acids, and their use in treating peripheral artery disease and intermittent claudication
|
WO2008088415A1
(en)
*
|
2006-10-18 |
2008-07-24 |
Reliant Pharmaceuticals, Inc. |
Omega-3 fatty acids for reduction of lp-pla2 levels
|
JP2010508262A
(ja)
|
2006-11-01 |
2010-03-18 |
プロノヴァ バイオファーマ ノルゲ アーエス |
組成物
|
CN101535238A
(zh)
*
|
2006-11-01 |
2009-09-16 |
普罗诺瓦生物医药挪威公司 |
作为过氧化物酶体增生物激活受体(PPAR)的活化剂或调节剂的α-取代的ω-3脂质
|
KR101544584B1
(ko)
*
|
2006-11-01 |
2015-08-13 |
프로노바 바이오파마 너지 에이에스 |
오메가-3 지질 화합물
|
BRPI0717972A2
(pt)
*
|
2006-11-01 |
2013-11-12 |
Pronova Biopharma Norge As |
Lipídeos de ômega-3 alfa-substituídos que são ativadores ou moduladores do receptor ativado por proliferadores de peroxissoma (ppar)
|
US20080125490A1
(en)
*
|
2006-11-03 |
2008-05-29 |
My Svensson |
Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
|
US20080306154A1
(en)
*
|
2006-11-03 |
2008-12-11 |
My Svensson |
Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids
|
US20100266681A1
(en)
*
|
2006-11-03 |
2010-10-21 |
Anne Kristin Holmeide |
Fatty acid alcohols
|
US20100130611A1
(en)
*
|
2006-12-20 |
2010-05-27 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
EP1967197A1
(de)
*
|
2007-03-09 |
2008-09-10 |
Cognis IP Management GmbH |
Verwendung von Präparationen, Aufreinigungen und Extrakten von Aloe
|
WO2009052182A1
(en)
|
2007-10-15 |
2009-04-23 |
Jbs United, Inc. |
Method for increasing performance of offspring
|
CN102552213A
(zh)
*
|
2007-06-29 |
2012-07-11 |
武田药品工业株式会社 |
无缝胶囊
|
US20090023808A1
(en)
*
|
2007-06-29 |
2009-01-22 |
Martek Biosciences Corporation |
Production and Purification of Esters of Polyunsaturated Fatty Acids
|
WO2009009040A2
(en)
*
|
2007-07-06 |
2009-01-15 |
Baum Seth J |
Fatty acid compositions and methods of use
|
EP2217558A1
(de)
*
|
2007-10-31 |
2010-08-18 |
Pronova Biopharma Norge AS |
Neue dha-derivate und ihre verwendung als medikamente
|
US8343753B2
(en)
*
|
2007-11-01 |
2013-01-01 |
Wake Forest University School Of Medicine |
Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
|
CA2704371A1
(en)
*
|
2007-11-01 |
2009-05-07 |
Wake Forest University School Of Medicine |
Compositions and methods for prevention and treatment of mammalian diseases
|
WO2009070589A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Jbs United, Inc. |
Method and composition for treating pulmonary hemorrhage
|
US8575409B2
(en)
|
2007-12-20 |
2013-11-05 |
Syntroleum Corporation |
Method for the removal of phosphorus
|
JP5421126B2
(ja)
|
2008-01-10 |
2014-02-19 |
武田薬品工業株式会社 |
カプセル製剤
|
US20090182049A1
(en)
*
|
2008-01-16 |
2009-07-16 |
Joar Arild Opheim |
Pharmaceutical Composition and Method for Treating Hypertriglyceridemia and Hypercholesterolemia in Humans
|
MX2010012482A
(es)
*
|
2008-05-15 |
2010-12-01 |
Pronova Biopharma Norge As |
Proceso para aceite de kril.
|
US8581013B2
(en)
|
2008-06-04 |
2013-11-12 |
Syntroleum Corporation |
Biorenewable naphtha composition and methods of making same
|
US20090300971A1
(en)
|
2008-06-04 |
2009-12-10 |
Ramin Abhari |
Biorenewable naphtha
|
MX2011001419A
(es)
|
2008-08-07 |
2011-05-25 |
Prodotti Antibiotici Spa |
Tratamiento a largo plazo de deficiencia cardiaca sintomatica.
|
DK2334295T3
(en)
*
|
2008-09-02 |
2017-10-09 |
Amarin Pharmaceuticals Ie Ltd |
PHARMACEUTICAL COMPOSITION COMPREHENSIVE EICOSAPENTAIC ACID AND NICOTIC ACID AND PROCEDURES FOR USING SAME
|
US20100062057A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Pronova BioPharma Norge AS. |
Formulation
|
US20100130608A1
(en)
*
|
2008-10-01 |
2010-05-27 |
Martek Biosciences Corporation |
Compositions and methods for reducing triglyceride levels
|
US8231804B2
(en)
|
2008-12-10 |
2012-07-31 |
Syntroleum Corporation |
Even carbon number paraffin composition and method of manufacturing same
|
US8563792B2
(en)
*
|
2008-12-16 |
2013-10-22 |
Cetane Energy, Llc |
Systems and methods of generating renewable diesel
|
EP2384192B1
(de)
|
2009-01-05 |
2017-10-25 |
Calanus AS |
Biologische ölzusammensetzung, formulierungen mit der ölzusammensetzung und ihre verwendung zur prävention bzw. behandlung von herz-kreislauf-erkrankungen
|
LT3037089T
(lt)
|
2009-02-10 |
2020-01-10 |
Amarin Pharmaceuticals Ireland Limited |
Eikozapentaeno rūgšties etilo esteris skirtas hipertriglicidemijai gydydti
|
JP6176894B2
(ja)
|
2009-03-09 |
2017-08-09 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用
|
US8241672B2
(en)
*
|
2009-03-11 |
2012-08-14 |
Stable Solutions Llc |
Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
|
US8993625B2
(en)
|
2009-03-11 |
2015-03-31 |
Stable Solutions Llc |
Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
|
US20110071090A1
(en)
*
|
2009-03-11 |
2011-03-24 |
Stable Solutions Llc |
Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
|
US9034389B2
(en)
|
2009-03-11 |
2015-05-19 |
Stable Solutions Llc |
Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
|
PT2429317T
(pt)
|
2009-04-17 |
2016-07-22 |
Natac Pharma S L |
Composições ricas em ácidos gordos ómega-3 com um teor baixo de ácido fitânico
|
AU2010241567B2
(en)
|
2009-04-29 |
2013-10-31 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
|
WO2010127103A1
(en)
|
2009-04-29 |
2010-11-04 |
Amarin Pharma, Inc. |
Stable pharmaceutical composition and methods of using same
|
US8455472B2
(en)
|
2009-06-15 |
2013-06-04 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
US9101942B2
(en)
|
2009-06-16 |
2015-08-11 |
Aurora Algae, Inc. |
Clarification of suspensions
|
US20110033531A1
(en)
*
|
2009-08-10 |
2011-02-10 |
Dracopharma, Inc. |
Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof
|
US20110033595A1
(en)
*
|
2009-08-10 |
2011-02-10 |
Rudolf Krumbholz |
Fatty acid fractionation process, fatty acid products and use thereof
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
JP5696150B2
(ja)
*
|
2009-09-10 |
2015-04-08 |
エフ エム シー コーポレーションFmc Corporation |
高い強度を有するシームレスなアルギン酸塩カプセル
|
KR101798670B1
(ko)
|
2009-09-23 |
2017-11-16 |
아마린 코포레이션 피엘씨 |
오메가-3 지방산 및 스타틴의 히드록시-유도체를 포함하는 제약 조성물 및 그의 사용 방법
|
US20110082205A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Panker Cynthia A |
Docosahexaenoic Acid Gel Caps
|
EP2488022B1
(de)
|
2009-10-16 |
2018-01-10 |
Mochida Pharmaceutical Co., Ltd. |
Zusammensetzungen
|
CA2781525C
(en)
*
|
2009-10-23 |
2020-05-12 |
Pronova Biopharma Norge As |
Coated capsules and tablets of a fatty acid oil mixture
|
AU2013204090B2
(en)
*
|
2009-12-30 |
2015-01-29 |
Basf Pharma (Callanish) Limited |
Simulated moving bed chromatographic separation process
|
RU2014146265A
(ru)
|
2009-12-30 |
2015-07-10 |
Басф Фарма (Калланиш) Лимитед |
Способ хроматографического разделения с псевдодвижущимся слоем
|
WO2011087981A2
(en)
|
2010-01-15 |
2011-07-21 |
E. I. Du Pont De Nemours And Company |
Clinical benefits of eicosapentaenoic acid in humans
|
RU2728825C2
(ru)
*
|
2010-03-04 |
2020-07-31 |
Амарин Фармасьютикалз Айрлэнд Лимитед (Апил) |
Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
|
US8394900B2
(en)
|
2010-03-18 |
2013-03-12 |
Syntroleum Corporation |
Profitable method for carbon capture and storage
|
WO2011143587A1
(en)
|
2010-05-13 |
2011-11-17 |
Nitromega Corp. |
Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
|
ITMI20100961A1
(it)
*
|
2010-05-27 |
2011-11-28 |
Erredue Spa |
Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione
|
EP2593141B1
(de)
*
|
2010-07-16 |
2018-07-04 |
Atrium Medical Corporation |
Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis
|
AR082930A1
(es)
*
|
2010-09-08 |
2013-01-16 |
Pronova Biopharma Norge As |
Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina
|
US20140017308A1
(en)
*
|
2010-09-08 |
2014-01-16 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
|
US20140004186A1
(en)
*
|
2010-09-08 |
2014-01-02 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
|
NZ727980A
(en)
|
2010-11-29 |
2018-08-31 |
Amarin Pharmaceuticals Ie Ltd |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
CL2010001587A1
(es)
|
2010-12-27 |
2013-01-11 |
Golden Omega S A |
Proceso de preparacion de un concentrado de etil esteres de acidos grasos omega-3 que comprende sobre el 80% en peso de dichos esteres en configuracion cis y sus dobles enlaces separados por una unidad metilenica.
|
US8715648B2
(en)
|
2011-02-16 |
2014-05-06 |
Pivotal Therapeutics Inc. |
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
|
US8951514B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
|
US8952000B2
(en)
|
2011-02-16 |
2015-02-10 |
Pivotal Therapeutics Inc. |
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
|
US9119826B2
(en)
|
2011-02-16 |
2015-09-01 |
Pivotal Therapeutics, Inc. |
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
|
EP2540292A1
(de)
*
|
2011-06-28 |
2013-01-02 |
Nestec S.A. |
DHA und EPA zur Reduktion oxidativer Belastung
|
US8865685B2
(en)
|
2011-06-30 |
2014-10-21 |
Johnson & Johnson Vision Care, Inc. |
Esters for treatment of ocular inflammatory conditions
|
GB201111595D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
Improved process
|
GB201111594D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
New improved process
|
GB201111589D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
New modified process
|
GB201111591D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
Further new process
|
GB201111601D0
(en)
|
2011-07-06 |
2011-08-24 |
Equateq Ltd |
New process
|
US20130131170A1
(en)
|
2011-11-07 |
2013-05-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
EP2776544A1
(de)
|
2011-11-09 |
2014-09-17 |
Evonik Membrane Extraction Technology Limited |
Membranbasierte verfahren zur verringerung von mindestens einer unreinheit und herstellung eines konzentrats mit mindestens einem natürlichen bestandteil aus einer nicht-marinen fettsäure-öl-mischung und zusammensetzungen daraus
|
KR101466617B1
(ko)
|
2011-11-17 |
2014-11-28 |
한미약품 주식회사 |
오메가-3 지방산 및 HMG-CoA 환원효소 억제제를 포함하는 안정성이 증가된 경구용 복합 제제
|
WO2013072767A1
(en)
|
2011-11-18 |
2013-05-23 |
Pronova Biopharma Norge As |
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
|
EP3348262A1
(de)
*
|
2012-01-06 |
2018-07-18 |
Omthera Pharmaceuticals Inc. |
Verfahren zur herstellung von dpa-angereicherten zusammensetzungen von mehrfach ungesättigten omega-3-fettsäuren in freier säureform
|
EP2800469B1
(de)
|
2012-01-06 |
2021-08-25 |
Amarin Pharmaceuticals Ireland Limited |
Zusammensetzungen und verfahren zur senkung der konzentration an hochsensitivem c-reaktiven protein (hs-crp) bei einer person
|
AU2013201793B2
(en)
*
|
2012-01-06 |
2015-03-19 |
Chrysalis Pharma Ag |
DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
|
EP2819675A4
(de)
*
|
2012-02-27 |
2015-07-22 |
Essentialis Inc |
Salze von kalium-atp-kanalöffnern und verwendungen davon
|
MY189576A
(en)
|
2012-03-30 |
2022-02-17 |
Micelle Biopharma Inc |
Omega-3 fatty acid ester compositions
|
US10898458B2
(en)
|
2012-03-30 |
2021-01-26 |
Micelle Biopharma, Inc. |
Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
|
US9480651B2
(en)
|
2012-03-30 |
2016-11-01 |
Sancilio & Company, Inc. |
Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
|
US20160228397A1
(en)
|
2012-03-30 |
2016-08-11 |
Sancilio & Company, Inc. |
Omega-3 fatty acid ester compositions
|
US8652518B2
(en)
|
2012-04-15 |
2014-02-18 |
Jahahreeh Finley |
Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
|
PT2659881T
(pt)
|
2012-04-30 |
2018-01-29 |
Tillotts Pharma Ag |
Formulação de fármaco de libertação retardada
|
JP6173437B2
(ja)
*
|
2012-05-07 |
2017-08-02 |
オムセラ・ファーマシューティカルズ・インコーポレイテッド |
スタチン及びω−3脂肪酸の組成物
|
KR102381331B1
(ko)
*
|
2012-05-14 |
2022-04-01 |
닛폰 스이산 가부시키가이샤 |
환경 오염 물질을 저감시킨 고도 불포화 지방산 또는 고도 불포화 지방산 에틸에스테르 및 그 제조 방법
|
WO2013192109A1
(en)
|
2012-06-17 |
2013-12-27 |
Matinas Biopharma, Inc. |
Omega-3 pentaenoic acid compositions and methods of use
|
RS61557B1
(sr)
|
2012-06-29 |
2021-04-29 |
Amarin Pharmaceuticals Ie Ltd |
Postupci za smanjenje rizika od kardiovaskularnog događaja kod pacijenta na terapiji statinom primenom etil estra eikozapentaenske kiseline
|
EP2897595B1
(de)
|
2012-09-24 |
2020-06-03 |
Aker Biomarine Antarctic As |
Omega-3-zusammensetzungen
|
WO2014060847A1
(en)
|
2012-09-24 |
2014-04-24 |
Aker Biopharma As |
Use of long chain polyunsaturated fatty acid derivatives to treat sickle cell disease
|
CA2889238A1
(en)
*
|
2012-10-23 |
2014-05-01 |
Deakin University |
Method for reducing triglycerides
|
WO2014074552A2
(en)
|
2012-11-06 |
2014-05-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
|
CA2894366A1
(en)
*
|
2012-12-06 |
2014-06-12 |
Matinas Biopharma, Inc. |
Methods of administering compositions comprising docosapentaenoic acid
|
US10123986B2
(en)
|
2012-12-24 |
2018-11-13 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (EPA) formulations
|
US9629820B2
(en)
|
2012-12-24 |
2017-04-25 |
Qualitas Health, Ltd. |
Eicosapentaenoic acid (EPA) formulations
|
US9814733B2
(en)
|
2012-12-31 |
2017-11-14 |
A,arin Pharmaceuticals Ireland Limited |
Compositions comprising EPA and obeticholic acid and methods of use thereof
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
GB201300354D0
(en)
|
2013-01-09 |
2013-02-20 |
Basf Pharma Callanish Ltd |
Multi-step separation process
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
US9662307B2
(en)
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
US20150374660A1
(en)
*
|
2013-02-26 |
2015-12-31 |
Jiva Pharma, Inc. |
Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses
|
US9328303B2
(en)
|
2013-03-13 |
2016-05-03 |
Reg Synthetic Fuels, Llc |
Reducing pressure drop buildup in bio-oil hydroprocessing reactors
|
US9283201B2
(en)
|
2013-03-14 |
2016-03-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating or preventing obesity in a subject in need thereof
|
US20140275613A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Aurora Algae, Inc. |
Conversion of free fatty acids to ethyl esters
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
US9266973B2
(en)
|
2013-03-15 |
2016-02-23 |
Aurora Algae, Inc. |
Systems and methods for utilizing and recovering chitosan to process biological material
|
US8969259B2
(en)
|
2013-04-05 |
2015-03-03 |
Reg Synthetic Fuels, Llc |
Bio-based synthetic fluids
|
US9428711B2
(en)
|
2013-05-07 |
2016-08-30 |
Groupe Novasep |
Chromatographic process for the production of highly purified polyunsaturated fatty acids
|
US8802880B1
(en)
|
2013-05-07 |
2014-08-12 |
Group Novasep |
Chromatographic process for the production of highly purified polyunsaturated fatty acids
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
WO2015011724A2
(en)
|
2013-07-22 |
2015-01-29 |
Kms Health Center Pvt Ltd |
A novel omega -3 fatty acid composition with a plant extract
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
KR102237356B1
(ko)
|
2013-10-29 |
2021-04-08 |
틸로츠 파마 아게 |
지연 방출 약물 제형
|
US9895332B2
(en)
*
|
2013-10-30 |
2018-02-20 |
Patheon Softgels, Inc. |
Enteric soft capsules comprising polyunsaturated fatty acids
|
CA2929954A1
(en)
*
|
2013-11-08 |
2015-05-14 |
Omega Protein Corporation |
Purification of dpa enriched oil
|
EP3118186B1
(de)
|
2013-12-11 |
2022-02-09 |
Novasep Process |
Chromatografische anlage zur herstellung von mehrfach ungesättigten fettsäuren
|
BR112016015718B1
(pt)
|
2014-01-07 |
2021-12-07 |
Novasep Process Solutions |
Processo de purificação de aminoácidos aromáticos
|
RU2741965C2
(ru)
|
2014-06-06 |
2021-02-01 |
Мэрин Ингридиэнтс, Ллк |
Композиции c омега-3, лекарственные формы и способы их применения
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
US10172818B2
(en)
|
2014-06-16 |
2019-01-08 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
US9895333B2
(en)
*
|
2014-06-26 |
2018-02-20 |
Patheon Softgels Inc. |
Enhanced bioavailability of polyunsaturated fatty acids
|
TWI532482B
(zh)
*
|
2014-09-01 |
2016-05-11 |
國立中山大學 |
阿魏酸用以製備提升血紅蛋白釋放氧氣至人體內各器官及周邊組織能力之藥物的用途
|
US10821090B2
(en)
*
|
2015-03-26 |
2020-11-03 |
Tiberio Bruzzese |
Purified compositions of polyunsaturated fatty acids, their preparation method and their use
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
WO2017035408A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
EP3219209A1
(de)
|
2016-03-19 |
2017-09-20 |
DMK Deutsches Milchkontor GmbH |
Lagerstabile milchzubereitung enthaltend ascorbinsäure
|
WO2018005552A1
(en)
|
2016-06-27 |
2018-01-04 |
Achillion Pharmaceuticals, Inc. |
Quinazoline and indole compounds to treat medical disorders
|
KR102632860B1
(ko)
|
2017-03-01 |
2024-02-02 |
아칠리온 파르마세우티칼스 인코포레이티드 |
의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물
|
IT201700054543A1
(it)
|
2017-05-19 |
2018-11-19 |
Gleaner Srls |
Preparato come fonte di Omega-3
|
US10966951B2
(en)
|
2017-05-19 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject having reduced kidney function
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
WO2019241563A1
(en)
|
2018-06-14 |
2019-12-19 |
Astrazeneca Uk Limited |
Methods for lowering triglyceride levels with a concentrated fish oil-based pharmaceutical composition
|
EP3586640A1
(de)
|
2018-06-21 |
2020-01-01 |
Nuseed Pty Ltd |
Dha-angereicherte mehrfach ungesättigte fettsäurezusammensetzungen
|
US20230022157A1
(en)
|
2018-08-20 |
2023-01-26 |
Achillion Pharmaceuticals, Inc. |
Pharmaceutical compounds for the treatment of complement factor d medical disorders
|
WO2020068163A1
(en)
|
2018-09-24 |
2020-04-02 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of cardiovascular events in a subject
|
KR20240012390A
(ko)
|
2021-04-21 |
2024-01-29 |
애머린 파마슈티칼스 아일랜드 리미티드 |
심부전의 위험을 감소시키는 방법
|